Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Assessing Coagulation Activation in DOAC – Treated Patients – JTH
Nov 16, 2026, 15:10

Assessing Coagulation Activation in DOAC – Treated Patients – JTH

Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Ashley Verburg et al., adding:

“Coagulation dynamics during coronary angiography in patients receiving chronic direct oral anticoagulants: insights from the randomized POPular MEASURE study.

POPular MEASURE examined coagulation during elective coronary angiography in 120 patients.

Eighty receiving chronic DOAC therapy were randomized to unfractionated heparin or placebo; 40 without oral anticoagulation received heparin as a reference cohort.

Omitting heparin in DOAC-treated patients was not associated with higher coagulation activation, assessed using prothrombin fragment 1 plus 2 and supporting laboratory markers.

This is a mechanistic study of surrogate outcomes. It does not establish clinical equivalence for procedural thrombosis or bleeding.”

Title: Coagulation dynamics during coronary angiography in patients receiving chronic direct oral anticoagulants: insights from the randomized POPular MEASURE study

Authors: Ashley Verburg, Wilbert Bor, Magdolna Nagy, Henri MH. Spronk, Hugo ten Cate,  Christian Hackeng, Jur ten Berg

Assessing Coagulation Activation in DOAC - Treated Patients - JTH

 

Stay updated on all scientific advances with Hemostasis Today.